Every weekend, I dig into our insider filings tracker looking for the biggest conviction buys — and this week was full of significant activity from both institutions and corporate leadership, with a continued focus on commodity stocks.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week checked all the boxes: Baker Bros, coal stocks, big software bets, and precious metals.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and today’s list delivered plenty of heavy hitters across biotech, energy, and asset management.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and today’s list brought a wide mix of energy names, miners, and even a notable move from Capitol Hill.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and today, the standout moves came straight from the top, with multiple CEOs stepping in across telecom, semis, and software.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we have action from deep-value investors and some of the world’s top hedge funds — all putting fresh money to work in key sectors...
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we’ve got notable activity across metals, crypto, construction, and insurance.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we’ve got heavy hitters across capital markets, biotech, real estate, and software.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, there’s a mix of biotech, asset management, industrials, and political filings making headlines.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we’ve got action across oil & gas, biotech, semiconductors, and more.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we’ve got everything from healthcare to energy to tech showing up.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week biotech was front and center, with some of the industry’s top funds putting fresh capital to work.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, biotech is stealing the spotlight with some heavyweight investors stepping in.
Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, the tape is packed with heavyweight moves from executives and funds alike.
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week’s list has some heavy hitters.
I’ve been tracking insider activity for years now. And over time, you start to get a feel for who really matters — whether it’s a CEO, a CFO, Warren Buffett, or even Nancy Pelosi with those political filings.
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and there was plenty of high-conviction activity this week.
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, it was private equity shops and hedge funds leading the charge.
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, we had a handful of Wall Street titans hit our list… as well as more activity in biotech....
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, we saw action from big hedge funds, leadership conviction, and an unusual political move...
Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, it’s all about institutional money, cluster buys, and CEOs putting skin in the game.
